Fifth Lane Capital, LP Bausch Health Companies Inc. Transaction History
Fifth Lane Capital, LP
- $27.8 Million
- Q4 2024
A detailed history of Fifth Lane Capital, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Fifth Lane Capital, LP holds 30,000 shares of BHC stock, worth $195,300. This represents 0.11% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$195,300% of portfolio
0.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$226 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$179 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$172 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$100 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$84.6 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.35B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...